Nu Skin Enterprises NUS releases its next round of earnings Thursday. Here's Benzinga's essential guide to Nu Skin's Q4 earnings report.
Earnings and Revenue
Nu Skin EPS will likely be near $1.19 while revenue will be around $665.44 million, according to analysts.
In the same quarter last year, Nu Skin reported EPS of 79 cents per share on revenue of $531.32 million. The analyst consensus estimate would represent a 50.63 percent increase in the company's EPS figure. Revenue would be up 25.24 percent on a year-over-year basis.
Here's how the company's reported EPS has stacked up against analyst estimates in the past:
Quarter | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 |
EPS Estimate | 0.76 | 0.69 | 0.5 | 0.8 |
EPS Actual | 0.76 | 0.77 | 0.51 | 0.79 |
Q4 EPS Estimate: $1.19
Q4 Revenues Estimate: $665 million
Stock Performance
Over the last 52-week period, shares are up 27.89 percent. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
Analyst estimates are adjusted higher for EPS and revenues over the past 90 days. The most common rating by analysts on Nu Skin stock is a Neutral. The strength of this rating has maintained conviction over the past three months.
Conference Call
Don't be surprised to see the stock move on comments made during its conference call. Nu Skin's Q4 conference call is scheduled to begin at 8:00 a.m. ET and can be accessed here: http://ir.nuskin.com/phoenix.zhtml?c=103888&p=irol-calendar
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.